Related by context. Frequent words. (Click for all words.) 76 dose escalation trial 76 Phase 2a trial 75 Phase 1b clinical 75 Phase 2a clinical 75 phase IIb 75 Phase 1b 74 Phase Ib 74 phase IIa 73 phase 2a 72 Phase 2a 72 Phase 2b trial 72 Phase 2b study 71 Phase IIa trial 70 dose escalation study 70 Phase IIa 70 Phase IIa clinical 70 Phase 2b 70 multiple ascending dose 69 single ascending dose 69 randomized Phase 69 Phase IIb trial 68 label dose escalation 68 Phase IIb clinical 68 dose escalation 68 Phase III 68 multicenter clinical 67 Phase 2b clinical 67 Phase III pivotal 67 Phase III clinical 67 pivotal Phase 67 pivotal Phase III 66 dose cohorts 66 Phase 66 placebo controlled 66 Phase IIb 66 multicentre 65 PXD# 65 PF # [001] 65 HGS ETR1 65 BAY #-# 65 multicenter randomized double 65 blind randomized placebo 65 Phase II 64 AP# [003] 64 TELCYTA 64 orally bioavailable 64 randomized placebo controlled 64 randomized controlled 64 unblinded 64 blind randomized 63 CA4P 63 multicenter 63 prospective randomized 63 blinded placebo controlled 63 randomized controlled clinical 63 clinical trial 63 Phase III trials 63 MGCD# [001] 62 hematological cancers 62 PRX# 62 safety tolerability pharmacokinetics 62 ISIS # 62 MDV# 62 randomized clinical 62 GRN#L 62 PS# [001] 62 CoFactor 61 Perifosine 61 ofatumumab 61 placebo controlled trials 61 pharmacodynamics 61 eculizumab 61 confirmatory Phase 3 61 OXi# 61 ASA# 61 Zerenex 61 VEGF Trap 61 cetrorelix 61 methylnaltrexone 61 HuMax CD# 61 tolerated dose MTD 61 valopicitabine 61 Phase III clinical trials 60 PRX # 60 panitumumab 60 NGX# 60 double blind placebo 60 RG# [001] 60 MLN# 60 IMGN# 60 INCB# [002] 60 denufosol 60 Amigal 60 sapacitabine 60 decitabine 60 refractory multiple myeloma 59 safety tolerability 59 Synavive 59 dose regimens 59 T DM1 59 IND enabling